dc.contributor.author | Weisel, Katja | |
dc.date.accessioned | 2019-01-16T15:41:50Z | |
dc.date.available | 2019-01-16T15:41:50Z | |
dc.date.issued | 2016 | |
dc.identifier.issn | 1178-6930 | |
dc.identifier.uri | http://hdl.handle.net/10900/85795 | |
dc.language.iso | en | en |
dc.publisher | Dove Medical Press Ltd | de_DE |
dc.relation.uri | http://dx.doi.org/10.2147/OTT.S94531 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject.ddc | 570 | de_DE |
dc.subject.ddc | 610 | de_DE |
dc.title | Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date | de_DE |
dc.type | Article | de_DE |
utue.quellen.id | 20180405102126_04237 | |
utue.personen.roh | Weisel, Katja | |
dcterms.isPartOf.ZSTitelID | Oncotargets and Therapy | de_DE |
dcterms.isPartOf.ZS-Volume | 9 | de_DE |
utue.fakultaet | 04 Medizinische Fakultät |
Dateien | Größe | Format | Anzeige |
---|---|---|---|
Zu diesem Dokument gibt es keine Dateien. |